These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 17690057)
1. Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. Sanger TD; Bastian A; Brunstrom J; Damiano D; Delgado M; Dure L; Gaebler-Spira D; Hoon A; Mink JW; Sherman-Levine S; Welty LJ; J Child Neurol; 2007 May; 22(5):530-7. PubMed ID: 17690057 [TBL] [Abstract][Full Text] [Related]
2. Pilot study on trihexyphenidyl in the treatment of dystonia in children with cerebral palsy. Rice J; Waugh MC J Child Neurol; 2009 Feb; 24(2):176-82. PubMed ID: 19182155 [TBL] [Abstract][Full Text] [Related]
3. Use of trihexyphenidyl in children with cerebral palsy. Carranza-del Rio J; Clegg NJ; Moore A; Delgado MR Pediatr Neurol; 2011 Mar; 44(3):202-6. PubMed ID: 21310336 [TBL] [Abstract][Full Text] [Related]
4. Trihexyphenidyl for dystonia in cerebral palsy. Harvey AR; Baker LB; Reddihough DS; Scheinberg A; Williams K Cochrane Database Syst Rev; 2018 May; 5(5):CD012430. PubMed ID: 29763510 [TBL] [Abstract][Full Text] [Related]
5. Correspondence on "Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy". Appendino JP; Soman T J Child Neurol; 2008 Jul; 23(7):846; author reply 846-7. PubMed ID: 18658086 [No Abstract] [Full Text] [Related]
6. Trihexyphenidyl improves motor function in children with dystonic cerebral palsy: a retrospective analysis. Ben-Pazi H J Child Neurol; 2011 Jul; 26(7):810-6. PubMed ID: 21498790 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of Oral Trihexyphenidyl Plus Clonazepam Versus Trihexyphenidyl for the Treatment of Dystonia in Children With Dystonic Cerebral Palsy: An Open-Label Randomized Controlled Trial. Kumar Panda P; Moirangthem V; Tomar A; Neyaz O; Sharawat IK Pediatr Neurol; 2024 Sep; 158():35-40. PubMed ID: 38945037 [TBL] [Abstract][Full Text] [Related]
9. The role of intrathecal baclofen in the management of primary and secondary dystonia in children. Woon K; Tsegaye M; Vloeberghs MH Br J Neurosurg; 2007 Aug; 21(4):355-8. PubMed ID: 17676454 [TBL] [Abstract][Full Text] [Related]
10. Upper limbs function after intrathecal baclofen therapy in children with secondary dystonia. Motta F; Antonello CE; Stignani C J Pediatr Orthop; 2009; 29(7):817-21. PubMed ID: 20104168 [TBL] [Abstract][Full Text] [Related]
11. High-dosage anticholinergic therapy in dystonia. Fahn S Adv Neurol; 1983; 37():177-88. PubMed ID: 6134442 [TBL] [Abstract][Full Text] [Related]
12. Trihexyphenidyl in young children with dystonic cerebral palsy: A single arm study. Rajkumar L; Ventatakrishnan A; Sairam S; Khosla M; Khanna R; Das B; Mishra D; Juneja M J Pediatr Rehabil Med; 2023; 16(1):115-124. PubMed ID: 36373299 [TBL] [Abstract][Full Text] [Related]
13. Can spasticity and dystonia be independently measured in cerebral palsy? Gordon LM; Keller JL; Stashinko EE; Hoon AH; Bastian AJ Pediatr Neurol; 2006 Dec; 35(6):375-81. PubMed ID: 17138005 [TBL] [Abstract][Full Text] [Related]
14. Effect of intrathecal baclofen on dystonia in children with cerebral palsy and the use of functional scales. Motta F; Stignani C; Antonello CE J Pediatr Orthop; 2008 Mar; 28(2):213-7. PubMed ID: 18388717 [TBL] [Abstract][Full Text] [Related]
15. Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study. Cubo E; Fernández Jaén A; Moreno C; Anaya B; González M; Kompoliti K Clin Ther; 2008 Jan; 30(1):182-9. PubMed ID: 18343255 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial. Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099 [TBL] [Abstract][Full Text] [Related]
17. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials. Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143 [TBL] [Abstract][Full Text] [Related]
18. Treatment of movement disorders with trihexyphenidyl. Jabbari B; Scherokman B; Gunderson CH; Rosenberg ML; Miller J Mov Disord; 1989; 4(3):202-12. PubMed ID: 2779591 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults. Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595 [TBL] [Abstract][Full Text] [Related]
20. Abnormalities of tactile sensory function in children with dystonic and diplegic cerebral palsy. Sanger TD; Kukke SN J Child Neurol; 2007 Mar; 22(3):289-93. PubMed ID: 17621498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]